• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

PI3Kα-IN-9

CAS No. 2715287-67-3

PI3Kα-IN-9 ( —— )

产品货号. M35579 CAS No. 2715287-67-3

PI3Kα-IN-9 (compound 27) 是一种有选择性的口服长效 PI3Kα 抑制剂 (PI3Kα inhibitor),对于 PI3Kα、PI3Kγ、PI3Kδ 和 PI3Kβ,其 IC50 值分别为 4.4、128、146 和 153 nM。PI3Kα-IN-9 具有抗增殖活性并诱导细胞凋亡。PI3Kα-IN-9 可用于癌症研究。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥672 有现货
5MG ¥993 有现货
10MG ¥1599 有现货
25MG ¥3558 有现货
50MG ¥5388 有现货
100MG ¥8339 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    PI3Kα-IN-9
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    PI3Kα-IN-9 (compound 27) 是一种有选择性的口服长效 PI3Kα 抑制剂 (PI3Kα inhibitor),对于 PI3Kα、PI3Kγ、PI3Kδ 和 PI3Kβ,其 IC50 值分别为 4.4、128、146 和 153 nM。PI3Kα-IN-9 具有抗增殖活性并诱导细胞凋亡。PI3Kα-IN-9 可用于癌症研究。
  • 产品描述
    PI3Kα-IN-9 (compound 27) is a selective, long-acting and oral active PI3Kα inhibitor with IC50 values of 4.4, 128, 146 and 153 nM for PI3Kα, PI3Kγ, PI3Kδ and PI3Kβ, respectively. PI3Kα-IN-9 has antiproliferative activity and induces apoptosis. PI3Kα-IN-9 can be used for cancer research.
  • 体外实验
    PI3Kα-IN-9 (compound 27) (0-8 μM; 72 hours; cancer cell lines) has antiproliferative activity and induces apoptosis.PI3Kα-IN-9 (compound 27) (0-8 μM; MGC-803 cells) down-regulates the expression of PI3Kα protein, the proteins of PI3K downstream, p-AKT and p-P70S6 K.Cell Viability Assay Cell Line:MGC-803 (gastric cancer), SKOV-3 (ovarian cancer), PC-3(prostate cancer), MCF-7 (breast cancer), MDA-MB-231 (triple-negative breast cancer), HepG2 (liver cancer), RPMI8226 (multiple myeloma), K562 (chronic myeloid leukemia), U251 (glioma) and MOLT-4 (acute lymphoblastic leukemia) cell lines Concentration:0-2 μM Incubation Time:72 hours Result:Inhibited the growth of a variety of cancer cells with IC50 values ranging from 0.43 to 1.33 μM.Apoptosis Analysis Cell Line:MGC-803 cells Concentration:0, 2, 4 and 8 μM Incubation Time:36 hours Result:Increased the percentage of apoptotic cells from 12.07 to 61.69% in a dose-dependent manner.
  • 体内实验
    PI3Kα-IN-9 (compound 27) (1-10 mg/kg; p.o. and i.v.; for 24 hours; male Sprague-Dawley rat) has favorable stability (T1/2>10 h) and high bioavailability (130%).PI3Kα-IN-9 (compound 27) (30 mg/kg; p.o.; daily, for 3 weeks; male BALB/c nude mice) has antitumor activity and low cytotoxicity.Animal Model:Male Sprague-Dawley ratDosage:1 and 10 mg/kg Administration:Oral administration and intravenous injection.Animal Model:Male BALB/c nude mice Dosage:30 mg/kg Administration:Oral administration; daily, for 3 weeks Result:Inhibited tumor growth with a tumor growth inhibition (TGI) rate of 41.5%.
  • 同义词
    ——
  • 通路
    Apoptosis
  • 靶点
    Apoptosis
  • 受体
    Apoptosis | PI3K
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2715287-67-3
  • 分子量
    383.4
  • 分子式
    C18H21N7O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO 中的溶解度 : 100 mg/mL (260.82 mM; 超声助溶 (<80°C)
  • SMILES
    N1=C(N=C(N=C1N2CCOCC2)N3CCOCC3)C4=CC=C5OC(=NC5=C4)N
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Hou Y, et, al. Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer. J Med Chem. 2022 Jul 14.?
产品手册
关联产品
  • BTT-3033

    BTT-3033 是一种具有口服活性的构象选择性的 α2β1 (EC50: 130 nM) 抑制剂,可与 α2I domain 结合。BTT-3033 抑制血小板与 collagen Ⅰ 结合和细胞增殖,并诱导细胞凋亡 (apoptosis)。BTT-3033 可用于前列腺癌、炎症和心血管疾病的研究。

  • Procyanidin C1

    原花青素 C1 是一种天然产物,具有抗炎作用,并诱导细胞凋亡。

  • PDK4-IN-1 hydrochlor...

    PDK4-IN-1 盐酸盐是一种蒽醌衍生物,是丙酮酸脱氢酶激酶 4 的有效口服活性抑制剂(PDK4,IC50 值 = 84 nM)。